# EDGAR Filing Document

**Accession Number:** 0001051219
**File Stem:** 0001162044-25-001099
**Filing Date:** 2025-10
**Character Count:** 20805
**Document Hash:** f57ddd29504991b9d12baefa0665cb71
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001162044-25-001099.hdr.sgml**: 20251029

**ACCESSION NUMBER**: 0001162044-25-001099

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250831

**FILED AS OF DATE**: 20251029

**DATE AS OF CHANGE**: 20251029

**PERIOD START**: 20251130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TANAKA FUNDS INC
- **CENTRAL INDEX KEY:** 0001051219

**ORGANIZATION NAME:**
- **EIN:** 541891278
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1130

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08683
- **FILM NUMBER:** 251428492

**BUSINESS ADDRESS:**
- **STREET 1:** 777 WEST PUTNAM AVENUE
- **STREET 2:** SUITE 300
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 2124903380

**MAIL ADDRESS:**
- **STREET 1:** 777 WEST PUTNAM AVENUE
- **STREET 2:** SUITE 300
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830

## Series and Classes Contracts Data

### TANAKA Growth Fund (Series ID: S000004755)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000012945 | Class R      | TGFRX           |

## Nport-Ex

---

| | | |
|:---|:---|:---|
| **Schedule of Investments** | **Schedule of Investments** | **Schedule of Investments** |
| **August 31, 2025 (unaudited)** | **August 31, 2025 (unaudited)** | **August 31, 2025 (unaudited)** |
| **<u>Tanaka Growth Fund</u>** | **<u>Tanaka Growth Fund</u>** | **<u>Tanaka Growth Fund</u>** |
|  | **Shares or Principal** |  |
| **Security Description** | **Amount ($)** | **Fair Value ($)(1)** |
| **Common Stocks - 99.80%** | **Common Stocks - 99.80%** | **Common Stocks - 99.80%** |
| **Accident & Health Insurance - 3.65%** |  |  |
| Aflac, Inc. | 8290  | 885869  |
| **Asset Management - 5.49%** |  |  |
| The Carlyle Group, Inc. | 20625  | 1331550  |
| **Base Metals - 3.88%** |  |  |
| United States Antimony Corp. (2) | 207000  | 941850  |
| **Beverages - 0.67%** |  |  |
| PepsiCo, Inc. | 1100  | 163515  |
| **Biotech - 6.39%** |  |  |
| Intellia Therapeutics, Inc. (2) | 45000  | 510975  |
| Nuvation Bio, Inc. (2) | 350000  | 1039500  |
|  |  | 1550475  |
| **Cigarettes - 2.38%** |  |  |
| Philip Morris International, Inc. | 3460  | 578270  |
| **Credit Services - 1.37%** |  |  |
| Mastercard, Inc. | 560  | 333362  |
| **Electronic Computers - 8.03%** |  |  |
| Apple, Inc.  | 8388  | 1947190  |
| **General Industrial Machinery & Equipment - 5.38%** |  |  |
| Symbotic, Inc. (2) | 27500  | 1304325  |
| **Internet Media & Services - 2.31%** |  |  |
| Meta Platforms, Inc. Class A  | 760  | 561412  |
| **Measuring & Controlling Device - 2.30%** |  |  |
| Onto Innovation, Inc. (2) | 5253  | 556818  |
| **Miscellaneous Metal Ores - 11.97%** |  |  |
| Aura Minerals, Inc. (British Virgin Islands) | 16500  | 481951  |
| Cameco Corp. (Canada) (2) | 6500  | 503035  |
| NexGen Energy Ltd. (Canada) (2) | 190889  | 1502701  |
| Uranium Energy Corp. (2) | 39000  | 416910  |
|  |  | 2904597  |
| **Pharmaceutical Preparations - 20.03%** |  |  |
| Catalyst Pharmaceuticals, Inc. (2) | 59098  | 1216828  |
| Corcept Therapeuticals, Inc. (2) | 52255  | 3643219  |
|  |  | 4860046  |
| **Radio & TV Broadcasting & Communications Equipment - 2.20%** |  |  |
| QUALCOMM, Inc. | 3323  | 534106  |
| **Renewable Energy Equipment - 3.25%** |  |  |
| Electrovaya, Inc. (2) | 130000  | 789100  |
| **Retail-Catalog & Mail-Order Houses - 2.53%** |  |  |
| Amazon.com, Inc. (2) | 2680  | 613720  |
| **Security Brokers, Dealers & Flotation Companies - 4.83%** |  |  |
| Stifel Financial Corp. | 10160  | 1171346  |
| **Semiconductors & Related Devices - 13.12%** |  |  |
| Applied Materials, Inc. | 3870  | 622141  |
| NVIDIA Corp. | 14700  | 2560446  |
|  |  | 3182587  |
| Total Common Stock | (Cost $8,573,056) | 24210140  |
| **Short-Term Investments - 0.32%** | **Short-Term Investments - 0.32%** | **Short-Term Investments - 0.32%** |
| Huntington Conservative Deposit Account - 4.16% (3) | 77130  | 77130  |
| Total Short-Term Investment Companies | (Cost $77,130) | 77130  |
| **Total Investments - 100.12%** | (Cost $8,650,186) | 24287270  |
| Liabilities Less Other Assets - (0.12%) |  | (28175) |
| Total Net Assets - 100.00% |  | 24259095  |
| (1) ***Statement on Financial Accounting Standard No. 157 "Fair Value Measurements"*** - Various inputs are used in determining the value of the Fund's investments. | (1) ***Statement on Financial Accounting Standard No. 157 "Fair Value Measurements"*** - Various inputs are used in determining the value of the Fund's investments. | (1) ***Statement on Financial Accounting Standard No. 157 "Fair Value Measurements"*** - Various inputs are used in determining the value of the Fund's investments. |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These inputs are summarized in the three broad levels listed below. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These inputs are summarized in the three broad levels listed below. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These inputs are summarized in the three broad levels listed below. |
| • Level 1 - quoted prices in active markets for identical securities | • Level 1 - quoted prices in active markets for identical securities | • Level 1 - quoted prices in active markets for identical securities |
| • Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.) | • Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.) | • Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.) |
| • Level 3 - significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments) | • Level 3 - significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments) | • Level 3 - significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of the inputs used as of August 29, 2025 in valuing the Fund's assets carried at fair value: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of the inputs used as of August 29, 2025 in valuing the Fund's assets carried at fair value: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of the inputs used as of August 29, 2025 in valuing the Fund's assets carried at fair value: |
|  | Investments in  | Other Financial |
| Valuation Inputs | Securities | Instruments (9) |
| Level 1 - Quoted Prices | $24287270 | - |
| Level 2 - Other Significant Observable Inputs | -  | - |
| Level 3 - Significant Unobservable Inputs | -  | - |
| Total | $24287270 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. For example, short-term | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. For example, short-term | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. For example, short-term |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;debt instruments and repurchase agreements with a maturity of less than 60 days are valued using amortized cost, in accordance with rules under the Investment | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;debt instruments and repurchase agreements with a maturity of less than 60 days are valued using amortized cost, in accordance with rules under the Investment | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;debt instruments and repurchase agreements with a maturity of less than 60 days are valued using amortized cost, in accordance with rules under the Investment |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company Act of 1940. Generally, amortized cost approximates the current fair value of a security, but since the value is not obtained from a quoted price in an active | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company Act of 1940. Generally, amortized cost approximates the current fair value of a security, but since the value is not obtained from a quoted price in an active | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company Act of 1940. Generally, amortized cost approximates the current fair value of a security, but since the value is not obtained from a quoted price in an active |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;market, such securities are reflected as Level 2. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;market, such securities are reflected as Level 2. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;market, such securities are reflected as Level 2. |
| (2) Represents non-income producing securities. | (2) Represents non-income producing securities. | (2) Represents non-income producing securities. |
| (3) Investment in affiliate. The yield shown represents the 7-day yield in effect at August 31, 2025. | (3) Investment in affiliate. The yield shown represents the 7-day yield in effect at August 31, 2025. | (3) Investment in affiliate. The yield shown represents the 7-day yield in effect at August 31, 2025. |
| # Total value for foreign common stock is $2,487,687, representing 10.25% of net assets.  | # Total value for foreign common stock is $2,487,687, representing 10.25% of net assets.  | # Total value for foreign common stock is $2,487,687, representing 10.25% of net assets.  |

---

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** TANAKA FUNDS INC

- **b. Investment Company Act file number:** 811-08683

- **c. CIK number of Registrant:** 0001051219

- **d. LEI of Registrant:** 54930073LAPJDABRWN22

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 777 West Putnam Avenue

  - **City:** Greenwich

  - **State:** CT

  - **Foreign country:** US

  - **Zip / Postal Code:** 06830

  - **Telephone number:** 212-490-3380

**Item A.2. Information about the Series.**

- **a. Name of Series:** Tanaka Growth Fund

- **b. EDGAR series identifier (if any):** S000004755

- **c. LEI of Series:** 54930042064FVO6TG342

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-11-30

- **b. Date as of which information is reported:** 2025-08-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $24308177.08

**Total Liabilities:** $49082.22

**Net Assets:** $24259094.86

**Cash Not Reported:** $77129.69

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000012945 | 3.94%                | 5.18%                | 5.09%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $593011.69               | $259979.37                                 |
| Month 2  | $0.00                    | $1173522.58                                |
| Month 3  | $370693.65               | $819842.59                                 |

### Schedule of Portfolio Investments

| Name                              | Title                             | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Aflac, Inc.                       | Aflac, Inc.                       | CUSIP: 001055102<br>LEI: 549300N0B7DOGLXWPP39 | Long             | EC               | CORP              | US        |      8290 | NS      | $885869.40    | 3.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Amazon.com, Inc.                  | Amazon.com, Inc.                  | CUSIP: 023135106<br>LEI: ZXTILKJKG63JELOEG630 | Long             | EC               | CORP              | US        |      2680 | NS      | $613720.00    | 2.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Apple, Inc.                       | Apple, Inc.                       | CUSIP: 037833100<br>LEI: HWUPKR0MPOU8FGXBT394 | Long             | EC               | CORP              | US        |      8388 | NS      | $1947190.32   | 8.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Applied Materials, Inc.           | Applied Materials, Inc.           | CUSIP: 038222105<br>LEI: 41BNNE1AFPNAZELZ6K07 | Long             | EC               | CORP              | US        |      3870 | NS      | $622141.20    | 2.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Aura Minerals, Inc.               | Aura Minerals, Inc.               | CUSIP: G06973104<br>LEI: 549300YIRI8PSDM2FV20 | Long             | EC               | CORP              | US        |     16500 | NS      | $481950.98    | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Blue Earth Resources, Inc         | Blue Earth Resources, Inc         | CUSIP: G11999102<br>LEI: 549300TO81ENOHW1NK80 | Long             | EC               | CORP              | US        |     27719 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Cameco Corp.                      | Cameco Corp.                      | CUSIP: 13321L108<br>LEI: N4BHALMXL3GMZKCUON55 | Long             | EC               | CORP              | CA        |      6500 | NS      | $503035.00    | 2.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Catalyst Pharmaceuticals, Inc.    | Catalyst Pharmaceuticals, Inc.    | CUSIP: 14888U101<br>LEI: 5299004O0R5XXLA5H544 | Long             | EC               | CORP              | US        |     59098 | NS      | $1216827.82   | 5.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Corcept Therapeutics, Inc.        | Corcept Therapeutics, Inc.        | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |     52255 | NS      | $3643218.60   | 15.02%            |  |  |  | No            |                  1 | On Loan: No      |
| Electrovaya, Inc.                 | Electrovaya, Inc.                 | CUSIP: 28617B606<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |    130000 | NS      | $789100.00    | 3.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics, Inc.       | Intellia Therapeutics, Inc.       | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |     45000 | NS      | $510975.00    | 2.11%             |  |  |  | No            |                  1 | On Loan: No      |
| MasterCard, Inc.                  | MasterCard, Inc.                  | CUSIP: 57636Q104<br>LEI: AR5L2ODV9HN37376R084 | Long             | EC               | CORP              | US        |       560 | NS      | $333362.40    | 1.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Meta Platforms, Inc.              | Meta Platforms, Inc. Class A      | CUSIP: 30303M102<br>LEI: BQ4BKCS1HXDV9HN80Z93 | Long             | EC               | CORP              | US        |       760 | NS      | $561412.00    | 2.31%             |  |  |  | No            |                  1 | On Loan: No      |
| NVIDIA Corp.                      | NVIDIA Corp.                      | CUSIP: 67066G104<br>LEI: 549300S4KLFTLO7GSQ80 | Long             | EC               | CORP              | US        |     14700 | NS      | $2560446.00   | 10.55%            |  |  |  | No            |                  1 | On Loan: No      |
| NexGen Energy Ltd.                | NexGen Energy Ltd.                | CUSIP: GSCAC9633<br>LEI: 529900N0IXNXB3IP7F06 | Long             | EC               | CORP              | US        |    190889 | NS      | $1502701.11   | 6.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio, Inc.                | Nuvation Bio, Inc.                | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    350000 | NS      | $1039500.00   | 4.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Onto Innovation, Inc.             | Onto Innovation, Inc.             | CUSIP: 683344105<br>LEI: 549300V1USTYXJ7TNR79 | Long             | EC               | CORP              | US        |      5253 | NS      | $556818.00    | 2.30%             |  |  |  | No            |                  1 | On Loan: No      |
| PepsiCo, Inc.                     | PepsiCo, Inc.                     | CUSIP: 713448108<br>LEI: FJSUNZKFNQ5YPJ5OT455 | Long             | EC               | CORP              | US        |      1100 | NS      | $163515.00    | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Philip Morris International, Inc. | Philip Morris International, Inc. | CUSIP: 718172109<br>LEI: HL3H1H2BGXWVG3BSWR90 | Long             | EC               | CORP              | US        |      3460 | NS      | $578269.80    | 2.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Qualcomm, Inc.                    | Qualcomm, Inc.                    | CUSIP: 747525103<br>LEI: H1J8DDZKZP6H7RWC0H53 | Long             | EC               | CORP              | US        |      3323 | NS      | $534105.79    | 2.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Stifel Financial Corp.            | Stifel Financial Corp.            | CUSIP: 860630102<br>LEI: 549300E5F07FE5GHJX84 | Long             | EC               | CORP              | US        |     10160 | NS      | $1171346.40   | 4.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Symbotic, Inc.                    | Symbotic, Inc. Class A            | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | US        |     27500 | NS      | $1304325.00   | 5.38%             |  |  |  | No            |                  1 | On Loan: No      |
| The Carlyle Group, Inc.           | The Carlyle Group, Inc.           | CUSIP: 14309L102<br>LEI: 529900NGGVF94UK6PG95 | Long             | EC               | CORP              | US        |     20625 | NS      | $1331550.00   | 5.49%             |  |  |  | No            |                  1 | On Loan: No      |
| United States Antimony Corp.      | United States Antimony Corp.      | CUSIP: 911549103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    207000 | NS      | $941850.00    | 3.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Uranium Energy Corp.              | Uranium Energy Corp.              | CUSIP: 916896103<br>LEI: 549300VD69WD2USLIP04 | Long             | EC               | CORP              | US        |     39000 | NS      | $416910.00    | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-08-29

**Name of Applicant:** Tanaka Funds Inc

**Signature:** /s/ Graham Tanaka

**Name of Signer:** Graham Tanaka

**Title:** President